video corpo

Roche Diagnostics Business Overview 2012 - 20 Pages

Add to MyMedicalExpo favorites
Roche Diagnostics Business Overview 2012

Catalog excerpts

Key Tests Test on the market* Business Area Ovarian cancer: aid in detection Oncology HE4 immunoassay CA125, CEA immunoassays Various cancer types: support diagnosis cobas 4800 BRAF V600 Mutation Test Melanoma: identification of patients carrying the V600E mutation in the BRAF gene companion diagnostic for Zelboraf cobas 4800 KRAS Mutation Test Colorectal cancer: identification of patients carrying a mutation in the KRAS gene companion diagnostic for EGFR-targeted therapies cobas 4800 EGFR Mutation Test Non-small cell lung cancer: identification of patients carrying a mutation in the EGFR...

 Open the catalog to page 2

Roche Diagnostics_ Business Areas/Unit_ Roche Professional Diagnostics 6 Roche Applied Science _12

 Open the catalog to page 3

Facts and Figures Sales by Business Area/Unit 2011 Employees: 27,380 Sales: 9,737 million CHF Growth: 6% (local currency) Tissue Diagnostics 6% Applied Science 8% Molecular Diagnostics 11% Professional Diagnostics 48% Diabetes Care 27% 11% 10% Tissue Diagnostics 6% Applied Science 8% Sales by region North America 25% Professional Diagnostics 48% 3% 27% Roche Diabetes Care Siemens Abbott Beckman bioMérieux EMEA (Europe, Middle East and Africa) 50% Latin America 7% Asia-Pacific 13% Japan 5% Source: Industry analyst report, Roche analysis, company reports, excludes Life Sciences and Insulin...

 Open the catalog to page 4

Competitive Advantages Total solution offering Breadth of technologies DNA/RNA-based Oncology Women’s health Metabolic diseases Strong commercial presence Active in all diagnostic segments Present in over 130 countries Large installed base worldwide 945,000,000 ER/ICU Physician’s office Elecsys tests sold in 2011 2,589,041 tests per day, 30 per second Japan APAC Accu-Chek Active meters sold worldwide Pathology lab 90% satisfied customers Patient Leader in Personalised Healthcare With its leading Pharmaceuticals and Diagnostics businesses under one roof, no other company is better positioned...

 Open the catalog to page 5

Business Strategy Roche Diagnostics differentiates itself in the marketplace through innovation in testing efficiency and medical value. – Focus on unmet needs Improving medical value – Get access & create IP – Deliver clinical evidence – Provide lab solutions Increasing testing efficiency 2012 – Offer complete menus 2020 ds Increase testing efficiency Provide true medical value With solutions for lab testing, information management, workflow integration and automation, we enable labs to better handle expanding testing and data volumes. We further drive lab efficiency by providing our lab...

 Open the catalog to page 6

Divisional Structure The Diagnostics Division is managed via a matrix organisation of Business Areas/ Unit, Regions and Global Functions. Business Areas/Unit – innovation excellence Business Areas Diagnostics Regions Global Functions Business Unit Business Areas/Unit are set up according to the fields of activities of our customers and are responsible for research and development, product portfolio manage- ment, global strategic direction and marketing, along with business development in their area of expertise. Life Science Professional Diagnostics Molecular Diagnostics Tissue Diagnostics...

 Open the catalog to page 7

Roche Professional Diagnostics 2011 Employees: 2,450 Sales: 4,686 million CHF (48% of divisional sales) Growth: 9% (local currency) Market share Professional diagnostics market Siemens 15.1% J&J OCD 5.7% Alere 4.2% bioMérieux 4.7% Others 32.1% Source: Industry analyst report, Roche analysis, company reports Sites Rotkreuz, Switzerland: Headquarters, Marketing, Medical Affairs, Business Development Mannheim and Penzberg, Germany, and Indianapolis, IN, USA: R&D, Production, Quality, Clinical Trials, Regulatory Affairs Roche Professional Diagnostics (RPD) is the largest Business Area. It is a...

 Open the catalog to page 8

Segments and products Serum work area: immunoassays and clinical chemistry With a broad portfolio of modular instruments, software and assays, SWA offers immunology and clinical chemistry systems for use by commercial labs, hospital core labs, medical centres, blood screening centres (in most countries outside US) and laboratory networks. The platforms can be combined in a flexible manner to fit the size of the lab and its required throughput. Platforms: cobas 4000 analyzer series (low-volume labs), cobas 6000 analyzer series (mid-volume labs), cobas 8000 modular analyzer series...

 Open the catalog to page 9

Roche Diabetes Care 2011 Employees: 5,500 Sales: 2,675 million CHF (27% of divisional sales) Growth: 2% (local currency) Market position Blood glucose monitoring market Blood glucose monitoring market Insulin delivery systems market Insulin delivery systems market Roche 13% Roche Diabetes Care (RDC) develops and commercia­ises blood glucose (bG) l monitoring and insulin delivery systems that enable people with diabetes to manage their condition more effectively. The goal of diabetes therapy is to maintain the bG levels in a (near-)normal range and thus avoid diabetes-related complications....

 Open the catalog to page 10

Segments and products Blood glucose monitoring BG meters are designed for self-monitoring of blood glucose, helping people with diabetes keep the blood glucose levels in a (near-)normal range by adjusting their medication – especially their insulin doses – according to their individual needs. Platforms: Meters: Accu-Chek Aviva, Accu-Chek Aviva Nano, Accu-Chek Nano SmartView, Accu-Chek Aviva Expert, Accu-Chek Performa, Accu-Chek Performa Nano, Accu-Chek Active, Accu-Chek Compact Plus, Accu-Chek Mobile Lancing systems: Accu-Chek Softclix, Accu-Chek Multiclix, Accu-Chek Fastclix Accu-Chek...

 Open the catalog to page 11

Roche Molecular Diagnostics 2011 Employees: 1,200 Sales: 1,094 million CHF (11% of divisional sales) Growth: 4% (local currency) Market position Molecular diagnostics market Molecular Diagnostics market bioMérieux 2% Cepheid 7% Siemens 4% Roche Molecular Diagnostics (RMD) develops and com­ ercialises advanced m diagnostics and blood screening platforms and tests based on Roche’s proprietary real-time Polyme­ ase Chain Reaction (PCR) r technology. PCR’s unique ability to exponentially amplify small amounts of target DNA has resulted in numerous diagnostic techniques which would otherwise be...

 Open the catalog to page 12

Archived catalogs

  1. Roche in Brief

    32 Pages

  2. Roche in Brief

    32 Pages